B+
Bull case
25%
Probability
Target price
$17.00
Analysis reference price unavailable
Analysis 2026-10-13 · RankAlpha Sentiment Codex
ANGO
AngioDynamicsDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Med Tech revenue grew 13.2%, led by Auryon, AlphaVac and NanoKnife, while adjusted EBITDA rose to $5.0 million from $2.2 million. If growth, reimbursement-driven utilization and cash conversion persist, the post-print selloff may prove excessive [#SEC-8K-2026-10-08].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -9.8.
What can break
Eric Honroth is due to succeed Jim Clemmer as CEO on November 2, creating transition execution risk [#SEC-8K-2026-10-08].
Momentum
6
Value
41
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $13.00 · Bull $17.00 · Bear $8.00Analysis 2026-10-13; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-13 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $18.33
Why
Momentum6 · Δ7d -9.2
Value41 · Δ7d +0.0
Sentiment49 · Δ7d -9.8
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -9.8.
Contradictions & invalidation
- • Eric Honroth is due to succeed Jim Clemmer as CEO on November 2, creating transition execution risk [#SEC-8K-2026-10-08].
- • FY2027 guidance was reiterated rather than raised, and Med Device sales grew only 1.4% in Q1 [#SEC-8K-2026-10-08].
- • Guidance was only reiterated, GAAP loss remained $7.1 million, cash declined after a $15.3 million quarterly operating outflow, and part of the reported margin benefited from tariff refunds.
Catalyst clock
2027-05-31
FY2027 guidance faces a post-earnings credibility test
Lead driver: Sentiment · See AI snapshot
Momentum
6
8% active weight
Current posture
7d trendFlat
Δ7d
-9.2
Δ21d
-68.3
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.3
Sentiment
49
45% active weight
Current posture
7d trendSoftening
Δ7d
-9.8
Δ21d
-20.8
Why this grade
Composite grade D. Momentum 6.5 / Value 41.2 / Sentiment 48.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-13. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$13.00
Analysis reference price unavailable
Analysis 2026-10-13 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$8.00
Analysis reference price unavailable
Analysis 2026-10-13 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$520M
Beta
0.52
Shares Out
42.05M
P/E (TTM) · Derived
-14.0
P/S (TTM)
1.81
P/FCF (TTM) · Derived
-167.32
Rev YoY
+8.0%
EPS YoY
+85.3%
Gross Margin
+51.3%
Op Margin
-7.0%
Net Debt
-$42.91M
Current Ratio
2.18
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data